DYN

Dyne Therapeutics
DYN

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$1.22B
EV
$601.17M
Shares Outstanding
113.12M
Beta
1.21

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$47.86
P/E 2025E
-
P/Revenue 2025E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Dyne Therapeutics, Inc.

gainify
DYN

Dyne Therapeutics, Inc.

DYN

Dyne Therapeutics, Inc., a clinical-stage muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It is developing a portfolio of muscle disease therapeutics, inclu...

Sector

Healthcare

Industry

Biotechnology

CEO

Cox, John

Employees

191

IPO Date

2020-09-17

Headquarters

1560 Trapelo Road, Waltham, Massachusetts, 02451, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved